{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:07:42Z","timestamp":1779430062770,"version":"3.53.1"},"reference-count":34,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["ASSAY and Drug Development Technologies"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:p>Voltage-gated calcium channels represent important drug targets. The implementation of higher throughput electrophysiology assays is necessary to characterize the interaction of test compounds with several conformational states of the channel, but has presented significant challenges. We report on the development of a high-throughput, automated electrophysiology assay for Cav2.2 on the IonWorks Barracuda\u2122 platform. The assay provides an assessment of the potency of the test compound on the resting\/closed and inactivated states of the channel in the same assay run. Inclusion of the heavy metal chelator 2,3-bis(sulfanyl)propane-1-sulfonate in the assay solutions improved the data quality by reversing a loss of current seen in wells directly above the ground electrodes. We hypothesize that the loss of current is caused by block of Cav2.2 currents by silver ions originating from the electrodes.<\/jats:p>","DOI":"10.1089\/adt.2015.678","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T16:08:06Z","timestamp":1451491686000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimization of a High-Throughput Assay for Calcium Channel Modulators on IonWorks Barracuda"],"prefix":"10.1177","volume":"14","author":[{"given":"Rok","family":"Cerne","sequence":"first","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Wakulchik","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolin","family":"Li","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Burris","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit T.","family":"Priest","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm3011433"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.08.027"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00004921"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb11874.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.81.5.613"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.784269"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.4.662"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2552"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2012.10.002"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2013.552"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/1087057112457414"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn959"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(03)00366-3"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.111.075226"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1039\/b706152h"},{"key":"e_1_3_2_17_2","first-page":"515","article-title":"Inhibition of Cav3.1 channel by silver ions","volume":"22","author":"Gromova P","year":"2003","unstructured":"Gromova P, , Kurejova M, , Lacinova L: Inhibition of Cav3.1 channel by silver ions. Gen Physiol Biophys, 2003; 22:515\u2013523.","journal-title":"Gen Physiol Biophys"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.23.040183.001205"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2014.10.001"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2004.01.003"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2008.136"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.06.003"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161207781368701"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00073"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1087057112456599"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/1386207311316030008"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2014.06.005"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(94)90100-7"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-01-00082.2002"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.04.075"},{"key":"e_1_3_2_31_2","unstructured":"Matsumura A Mikamiyama H Shao B Tsuno N Yao J: Benzenesulfonamide Compounds and the Use thereof. US 2009\/0306136 A1. 2009."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)10504-X"},{"key":"e_1_3_2_33_2","unstructured":"Heer JP Norton D Ward SE: Novel Derivatives. US 2010\/0016330 A1. 2010."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00374372"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2007.03.005"}],"container-title":["ASSAY and Drug Development Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/adt.2015.678","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/adt.2015.678","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/adt.2015.678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:39:05Z","timestamp":1779428345000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/adt.2015.678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1089\/adt.2015.678"],"URL":"https:\/\/doi.org\/10.1089\/adt.2015.678","relation":{},"ISSN":["1540-658X","1557-8127"],"issn-type":[{"value":"1540-658X","type":"print"},{"value":"1557-8127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}